![Charles Monahan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Charles Monahan
Consigliere Generale presso CARDIFF ONCOLOGY, INC.
Profilo
Charles Monahan is currently the Senior Vice President-Regulatory Affairs at Cardiff Oncology, Inc. His former job was as the Global Head-Regulatory Affairs at ERYTech Pharma SA from 2017 to 2021.
He received his undergraduate degree from the University of Rhode Island and his graduate degree from Massachusetts College of Pharmacy & Health Science.
Posizioni attive di Charles Monahan
Società | Posizione | Inizio |
---|---|---|
CARDIFF ONCOLOGY, INC. | Consigliere Generale | 11/01/2022 |
Precedenti posizioni note di Charles Monahan
Società | Posizione | Fine |
---|---|---|
ERYTech Pharma SA
![]() ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France. | Consigliere Generale | 01/12/2021 |
Formazione di Charles Monahan
University of Rhode Island | Undergraduate Degree |
Massachusetts College of Pharmacy & Health Science | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
CARDIFF ONCOLOGY, INC. | Health Technology |
Aziende private | 1 |
---|---|
ERYTech Pharma SA
![]() ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France. | Health Technology |
- Borsa valori
- Insiders
- Charles Monahan